Patrick McGann

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (15)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (10)

Sarah H. O’Brien

UNITED STATES

View details

Seethal Jacob

Assistant Professor of Pediatrics

Riley Hospital for Children at Indiana University Health

UNITED STATES

View details

Angela C. Weyand

UNITED STATES

View details

John Perentesis

Professor of Pediatrics & Institute Director

Cincinnati Children's Hospital Medical Center

UNITED STATES

View details

Madeleine Verhovsek

CANADA

View details

Russell E. Ware

UNITED STATES

View details

Susan E. Creary

UNITED STATES

View details

Jonathan Spector

Novartis Institutes for BioMedical Research Inc

UNITED STATES

View details

Charles Quinn

Professor

Cincinnati Children's Hospital Medical Center

UNITED STATES

View details

Kristine Karkoska

University of Cincinnati

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Patrick McGann

Research Interests

Explore related searches

Contact this professor

Articles (15)

Accelerated drug approvals and patient trust: impact of voxelotor and crizanlizumab for sickle cell disease

Sickle cell trait does not cause “sickle cell crisis” leading to exertion-related death: a systematic review

Hematology training in Africa: from brain drain to brain gain

Non – Invasive, smartphone image-based screening for sickle cell disease at the point-of-need

Sickle cell disease in India: Not just a mild condition

Hydroxyurea in pregnancy: Reframing the conversation

Early diagnosis of sickle cell disease at birth hospitals and vaccination centers in Angola using point-of-care tests

Hydroxyurea for children with sickle cell disease in sub‐Saharan Africa: A summary of the evidence, opportunities, and challenges

Early hydroxyurea use is neuroprotective in children with sickle cell anemia

US News & World Report and quality metrics: Inclusion of sickle cell disease is a matter of equity

Lessons learned from the COVID-19 pandemic blood supply crisis.

Impact of hydroxyurea dose and adherence on hematologic outcomes for children with sickle cell anemia

Enablers and barriers to newborn screening for sickle cell disease in Africa: results from a qualitative study involving programmes in six countries.

System's failure: Poor adherence to guidelines for children with sickle cell disease

Saving lives through early diagnosis: the promise and role of point of care testing for sickle cell disease

Collaborators (10)

Sarah H. O’Brien

Seethal Jacob

Angela C. Weyand

John Perentesis

Madeleine Verhovsek

Russell E. Ware

Susan E. Creary

Jonathan Spector

Charles Quinn

Kristine Karkoska

Make your next move.

Patrick McGann

Research Interests

Explore related searches

Contact this professor

Articles (15)

Accelerated drug approvals and patient trust: impact of voxelotor and crizanlizumab for sickle cell disease

Sickle cell trait does not cause “sickle cell crisis” leading to exertion-related death: a systematic review

Hematology training in Africa: from brain drain to brain gain

Non – Invasive, smartphone image-based screening for sickle cell disease at the point-of-need

Sickle cell disease in India: Not just a mild condition

Hydroxyurea in pregnancy: Reframing the conversation

Early diagnosis of sickle cell disease at birth hospitals and vaccination centers in Angola using point-of-care tests

Hydroxyurea for children with sickle cell disease in sub‐Saharan Africa: A summary of the evidence, opportunities, and challenges

Early hydroxyurea use is neuroprotective in children with sickle cell anemia

US News &amp; World Report and quality metrics: Inclusion of sickle cell disease is a matter of equity

Lessons learned from the COVID-19 pandemic blood supply crisis.

Impact of hydroxyurea dose and adherence on hematologic outcomes for children with sickle cell anemia

Enablers and barriers to newborn screening for sickle cell disease in Africa: results from a qualitative study involving programmes in six countries.

System's failure: Poor adherence to guidelines for children with sickle cell disease

Saving lives through early diagnosis: the promise and role of point of care testing for sickle cell disease

Collaborators (10)

Sarah H. O’Brien

Seethal Jacob

Angela C. Weyand

John Perentesis

Madeleine Verhovsek

Russell E. Ware

Susan E. Creary

Jonathan Spector

Charles Quinn

Kristine Karkoska

Make your next move.

US News & World Report and quality metrics: Inclusion of sickle cell disease is a matter of equity